{"product_id":"encompasshealth-five-forces-analysis","title":"Encompass Health Porter's Five Forces Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eFrom Overview to Strategy Blueprint\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eEncompass Health operates in a competitive post-acute care market where buyer bargaining, reimbursement pressures, and consolidation shape margins, while regulatory hurdles and substitute care models pose notable threats. This brief snapshot only scratches the surface. Unlock the full Porter's Five Forces Analysis to explore Encompass Health’s competitive dynamics, market pressures, and strategic advantages in detail.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003euppliers Bargaining Power\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eClinical labor scarcity\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSpecialized therapists, nurses, and rehab physicians are core inputs and remain in short supply, elevating wage pressure and turnover risk. Reliance on travel staff and premium pay to fill gaps compresses margins and raises operating volatility. Strong employer brand and residency affiliations reduce supplier leverage by improving recruitment. Automation and scheduling efficiency help, but cannot fully offset scarcity given projected 18% demand growth for physical therapists (BLS 2022–32).\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTherapy equipment and devices\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eTherapy equipment and devices for Encompass Health—notably rehab robotics, mobility aids and specialty devices—are sourced from a concentrated vendor base, with the global rehab robotics market estimated at about $1.2 billion in 2023. Switching costs are moderate due to staff training, protocol changes and clinical-pathway integration. Volume purchasing and device standardization can reduce supplier leverage. Supply-chain disruptions (semiconductor and component shortages) can tighten availability and raise prices.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDrugs and medical supplies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eWhile many hospital supplies are commoditized, injectables and specialty medicines retain pricing power, with specialty drugs accounting for roughly half of US drug spending in 2023. Group purchasing organizations, which serve about 90% of US hospitals, improve pricing but cannot remove inflation or supply shocks. Formularies and clinical protocols help rationalize use and curb cost growth. Reliable logistics remain critical to avoid care disruptions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIT\/EMR and interoperability\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eEMR, analytics, and interoperability vendors create strong lock-in through proprietary data models, workflows, and regulatory compliance requirements; Epic and Oracle Cerner held roughly 60% of US hospital EMR market in 2024. Integration with referring hospitals raises switching friction, while multi-year (commonly 5–7 year) contracts and multi-million-dollar implementations amplify vendor leverage; strict cybersecurity and uptime SLAs further constrain alternatives.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eVendor concentration: Epic\/Oracle Cerner ~60% (2024)\u003c\/li\u003e\n\u003cli\u003eContract length: 5–7 years\u003c\/li\u003e\n\u003cli\u003eImplementation: multi-million-dollar\u003c\/li\u003e\n\u003cli\u003eDrive factors: data\/workflow lock-in, hospital integration, cyber\/uptime SLAs\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eFacility development and services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cpfacility development and services: construction facilities management imaging partners materially affect encompass health cost timelines for new hospitals operated in increasing capex exposure scale needs. intensity raises dependence on a limited pool of qualified contractors regional market tightness has pushed contractor bids higher some metros. long-term service agreements can stabilize costs but reduce operational flexibility.\u003e\n\u003cp\u003e\u003c\/p\u003e\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eContractor concentration: higher bargaining power\u003c\/li\u003e\n\u003cli\u003eCapex scale: 137 hospitals (2024) increases supplier leverage\u003c\/li\u003e\n\u003cli\u003eRegional tightness: bids up ~10–15%\u003c\/li\u003e\n\u003cli\u003eLong-term contracts: cost stability vs reduced flexibility\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pfacility\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eClinician shortages and device concentration tighten supplier power, raising wage and supply risk\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSupplier power is moderate-high: clinician scarcity (PT demand +18% 2022–32) and travel-staff reliance raise wage pressure and margin volatility. Device\/vendor concentration (rehab robotics ~$1.2B 2023) and EMR lock-in (Epic\/Oracle Cerner ~60% 2024) increase switching costs. GPOs (~90% hospitals) and long-term contracts mitigate but cannot remove pricing or supply shocks.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003ePT demand growth\u003c\/td\u003e\n\u003ctd\u003e+18% (BLS 2022–32)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRehab robotics market\u003c\/td\u003e\n\u003ctd\u003e$1.2B (2023)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEMR share\u003c\/td\u003e\n\u003ctd\u003eEpic\/Cerner ~60% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHospitals\u003c\/td\u003e\n\u003ctd\u003e137 (Encompass 2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGPO coverage\u003c\/td\u003e\n\u003ctd\u003e~90% US hospitals\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eContractor bids\u003c\/td\u003e\n\u003ctd\u003e+10–15% regional\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eTailored exclusively for Encompass Health, this Porter's Five Forces analysis uncovers key drivers of competition, buyer and supplier influence, substitution threats, and entry barriers, highlighting disruptive trends and strategic levers that impact pricing, profitability, and market positioning.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA concise, one-sheet Porter's Five Forces for Encompass Health that pinpoints competitive intensity, payer\/reimbursement and regulatory risks, and supplier\/entry threats—customizable for scenario analysis and slide-ready to eliminate research and presentation bottlenecks.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eustomers Bargaining Power\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMedicare and Medicaid rate setting\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMedicare FFS sets the IRF base rate through the IRF PPS, effectively capping prices and limiting Encompass Health’s negotiation; CMS’s FY2024 IRF PPS update (net ~3.1% increase) and case-mix adjustments directly shift revenue. Medicaid reimbursement varies by state and is often below cost, pressuring margins. Regulatory visibility is moderate, but periodic CMS resets can produce material payment swings.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMedicare Advantage concentration\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMedicare Advantage enrollment topped 30 million in 2024, with top insurers capturing roughly 55–60% of enrollment in many markets, boosting plan negotiating leverage. Plans steer volume via narrow networks and prior authorization, shifting admissions and case mix. Aggressive discounts and utilization controls compress rates and length-of-stay, pressuring margins. Proven functional and readmission outcomes can earn preferred status and higher referral share.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCommercial payers and ACOs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eCommercial insurers and ACOs increasingly push site-of-care shifts to lower-cost alternatives and use bundled payments and value-based contracts to scrutinize post-acute spend. Contract renewals hinge on outcomes, readmissions and cost per episode, with CMS readmission penalties up to 3% reinforcing this pressure. Larger integrated systems consistently extract better commercial terms than fragmented providers.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHospital discharge planners\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eHospital discharge planners act as gatekeepers for Encompass Health referrals, with acute-care placement decisions heavily swaying volumes; Encompass, the largest US post-acute provider, operated over 140 inpatient rehab hospitals in 2024, and co-located JVs demonstrably ease transfers and boost referral flow. Performance on throughput and care coordination directly changes discharge choices, so relationship management materially affects share.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eGatekeeping: acute hospitals control referrals\u003c\/li\u003e\n\u003cli\u003eCo-located JVs: lower friction, higher flow\u003c\/li\u003e\n\u003cli\u003eThroughput\/care coordination: impacts placement\u003c\/li\u003e\n\u003cli\u003eRelationship management: drives volume\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePatients and caregivers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eIndividual patients have limited pricing power for Encompass Health because payers and clinical protocols determine coverage; in 2024 Encompass operated 137 inpatient rehab hospitals and ~257 home health\/hospice sites, keeping consumer choice bounded by location and network. Patient satisfaction and functional outcomes strongly influence referrals and reputation, while price transparency tools are growing but remain secondary to payer networks.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eLow direct pricing power\u003c\/li\u003e\n\u003cli\u003eNetworks\/location limit choice\u003c\/li\u003e\n\u003cli\u003eOutcomes drive referrals\u003c\/li\u003e\n\u003cli\u003eTransparency rising but less decisive\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePayers hold leverage; MA \u003cstrong\u003e\u0026gt;30M\u003c\/strong\u003e, top plans \u003cstrong\u003e~55–60%\u003c\/strong\u003e; Medicare IRF PPS \u003cstrong\u003e+3.1%\u003c\/strong\u003e risked\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePayers (Medicare FFS\/MA, Medicaid, commercial) hold strong bargaining power via rate-setting, prior auth and network steering; Medicare FY2024 IRF PPS net +3.1% but CMS resets can swing revenue. MA enrollment \u0026gt;30M (2024) with top plans at ~55–60% market share, pressuring rates and LOS. Hospitals gatekeep referrals; Encompass ran 137 IRFs and ~257 home health\/hospice sites in 2024, limiting patient choice.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024 Value\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eMA enrollment\u003c\/td\u003e\n\u003ctd\u003e30+ million\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTop plan share\u003c\/td\u003e\n\u003ctd\u003e~55–60%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEncompass IRFs\u003c\/td\u003e\n\u003ctd\u003e137\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHome health\/hospice sites\u003c\/td\u003e\n\u003ctd\u003e~257\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCMS FY2024 IRF PPS\u003c\/td\u003e\n\u003ctd\u003enet +3.1%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCMS readmission penalty\u003c\/td\u003e\n\u003ctd\u003eup to 3%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You See Is What You Get\u003c\/span\u003e\u003cbr\u003eEncompass Health Porter's Five Forces Analysis\u003c\/h2\u003e\n\u003cp\u003eThis preview shows the exact Encompass Health Porter’s Five Forces analysis you'll receive immediately after purchase—no surprises or placeholders. The document is fully formatted, professionally written, and ready for download and use the moment you buy. You're viewing the final deliverable and will get instant access to this identical file upon payment.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"PortersFiveForce","offers":[{"title":"Default Title","offer_id":56163298935161,"sku":"encompasshealth-five-forces-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0914\/5276\/8633\/files\/encompasshealth-five-forces-analysis.png?v=1762716841","url":"https:\/\/portersfiveforce.com\/products\/encompasshealth-five-forces-analysis","provider":"Porter's Five Forces","version":"1.0","type":"link"}